Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

GlaxoSmithKline (GSK) ADRs (Each Representing 2 Ord 0.25p Shares)

Sell:$45.99 Buy:$46.00 Change: $0.30 (0.64%)
Market closed |  Prices as at close on 12 December 2019 | Switch to live prices |
Ex-dividend
Sell:$45.99
Buy:$46.00
Change: $0.30 (0.64%)
Market closed |  Prices as at close on 12 December 2019 | Switch to live prices |
Ex-dividend
Sell:$45.99
Buy:$46.00
Change: $0.30 (0.64%)
Market closed |  Prices as at close on 12 December 2019 | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.

Contact details

Address:
G S K House, 980 Great West Road
BRENTFORD
TW8 9GS
United Kingdom
Telephone:
+44 (20) 80475000
Website:
https://www.gsk.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
GSK
ISIN:
US37733W1053
Market cap:
$114.77 billion
Shares in issue:
4.99 billion
Sector:
Pharmaceuticals
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Emma Walmsley
    Chief Executive Officer, Executive Director
  • Iain Mackay
    Chief Financial Officer, Executive Director
  • Roger Connor
    President - Vaccines
  • Brian McNamara
    Chief Executive Officer - GSK Consumer Healthcare
  • Luke Miels
    President - Global Pharmaceuticals
  • Regis Simard
    President - Pharmaceutical Supply Chain
  • Phil Thomson
    President - Global Affairs
  • James Ford
    Senior Vice President, General Counsel
  • Claire Thomas
    Senior Vice President - Human Resources
  • Nick Hirons
    Senior Vice President – Global Ethics and Compliance

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.